The Cross-sectional and Longitudinal Associations of Diabetic Retinopathy With Cognitive Function and Brain MRI Findings: The Action to Control Cardiovascular.

Slides:



Advertisements
Similar presentations
Corpus Callosum Damage Predicts Disability Progression and Cognitive Dysfunction in Primary-Progressive MS After Five Years.
Advertisements

Reductions in Regimen Distress Are Associated With Improved Management and Glycemic Control Over Time Featured Article: Danielle Hessler, Lawrence Fisher,
THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*
Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity Featured Article: Ricardo V. Cohen, M.D., Jose C. Pinheiro, M.D.,
Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin Featured Article: Beverley Balkau, Philip D. Home, Maya Vincent,
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
Disclosures/Conflicts Consulting: GE Healthcare Bayer Abbott Elan/Janssen Synarc Genentech Merck.
Effect of Physician Asthma Education on Health Care Utilization of Children at Different Income Levels Randall Brown, Noreen Clark, Niko Kaciroti, Molly.
Severe Hypoglycemia and Mortality After Cardiovascular Events for Type 1 Diabetic Patients in Sweden Featured Article: Tom W.C. Lung, Dennis Petrie, William.
The Effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for Patients With Diabetes and Subclinical Depression: Results of a Randomized.
Is There a Link Between Liraglutide and Pancreatitis? A Post Hoc Review of Pooled and Patient-Level Data From Completed Liraglutide Type 2 Diabetes Clinical.
Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial Featured Article: Ravi Retnakaran, Caroline K.
Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
An Automated Internet Behavioral Weight-Loss Program by Physician Referral: A Randomized Controlled Trial Featured Article: J. Graham Thomas, Tricia M.
Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S. Featured Article:
Individualizing Targets and Tactics for High- Risk Patients With Type 2 Diabetes Practical lessons from ACCORD and other cardiovascular trials Featured.
Yaffe K, Laffan AM, et al. Sleep-disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women. JAMA.2011;306(6):
Ali Ardestani, David Rhoads, Ali Tavakkoli
Meredith Cook – PharmD Candidate Mercer University COPHS August, 2012 Cognitive Trajectories after Postoperative Delirium.
Impact of Socioeconomic Status on Cardiovascular Disease and Mortality in 24,947 Individuals With Type 1 Diabetes Featured Article: Araz Rawshani, Ann-Marie.
Neurological Consequences of Diabetic Ketoacidosis at Initial Presentation of Type 1 Diabetes in a Prospective Cohort Study of Children Featured Article:
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Brain Atrophy in Type 2 Diabetes Regional distribution and influence on cognition Featured Article: Chris Moran, M.B., B.C.H., Thanh G. Phan, P.H.D., Jian.
Magnetic Resonance Neuroimaging Study of Brain Structural Differences in Diabetic Peripheral Neuropathy Featured Article: Dinesh Selvarajah, Iain D. Wilkinson,
The Relationship of Urologic Complications With Health- Related Quality of Life and Perceived Value of Health in Men and Women with Type 1 Diabetes: The.
Relational Discord at Conclusion of Treatment Predicts Future Substance Use for Partnered Patients Wayne H. Denton, MD, PhD; Paul A. Nakonezny, PhD; Bryon.
Risk Factors for Decline in IQ in Youth With Type 1 Diabetes Over the 12 Years From Diagnosis/Illness Onset Featured Article: Ashleigh Lin, Elisabeth A.
Microstructural White Matter Abnormalities and Cognitive Functioning in Type 2 Diabetes A Diffusion Tensor Imaging Study Featured Article: Yael D. Reijmer,
Long-Term Complications and Mortality in Young-Onset Diabetes Type 2 diabetes is more hazardous and lethal than type 1 diabetes Featured Article: Maria.
Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial Featured Article: TODAY Study Group* Diabetes Care Volume 36:
Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults Featured Article: Peter T. Campbell, Ph.D., Christina C. Newton,
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.
Haptoglobin 1-1 Genotype is Associated With Poorer Cognitive Functioning in the Elderly With Type 2 Diabetes Featured Article: Ramit Ravona-Springer, M.D.,
Racial Comparisons of Diabetes Care and Intermediate Outcomes in a Patient-Centered Medical Home Featured Article: Joseph A. Simonetti, Michael J. Fine,
New 2011 SHIFT quality of life substudy Quality of life ( QoL) in heart failure: where do we stand? Therapies that have survival benefits either have a.
Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes Featured Article: Andrzej S. Krolewski, M.D., Ph.D., James H. Warram,
High Concentrations of AGE-LDL and Oxidized LDL in Circulating Immune Complexes Are Associated With Progression of Retinopathy in Type 1 Diabetes Featured.
Short- and Long-Term Mortality After Myocardial Infarction in Patients With and Without Diabetes Featured Article: Sjoerd T. Nauta, M.S.C., Jaap W. Deckers,
Trends in Diabetes Incidence: The Framingham Heart Study Featured Article: Tobin M. Abraham, Karol M. Pencina, Michael J. Pencina, and Caroline S. Fox.
Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes Featured Article: Ruth S. Weinstock, Stephanie N. DuBose, Richard.
Journal Club Julie Shah, MD Milton S Hershey Medical Center Penn State University.
Adeline SL Ng, Amanda RJ Ng, Ivane Chew, Nagaendran Kandiah Department of Neurology, National Neuroscience Institute, Singapore APOE4 status modulates.
DIABETES AS A RISK FACTOR FOR COGNITIVE DECLINE IN OLDER PATIENTS F. Limongi, A. Marseglia, S. Maggi, M. Noale, G. Romanato, P. Siviero, G. Crepaldi CNR,
The ACCORD Trial: Review of Design and Results
The SPRINT Research Group
ACCORD Design and Baseline Characteristics
Does intensive glucose control prevent cognitive decline in diabetes
Volume 386, Issue 9988, Pages (July 2015)
LEADER trial: Primary Outcome
Alcohol, Other Drugs, and Health: Current Evidence March–April 2017
National Academy of Neuropsychology
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:
Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study  Vasilios Papademetriou, MD, DSc, Eric.
Prevalence of depression severity according to the stage of diabetic nephropathy. Prevalence of depression severity according to the stage of diabetic.
Subgroup analysis. Subgroup analysis. Effect of vitamin D supplementation on outcome variables in subgroups defined by baseline levels of the respective.
Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics:
Baseline Characteristics of the Study Participants
Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.
Participation in Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Hisao Ogawa et al. JAMA 2008;300:
Receiver operating characteristic curves for the association of primary outcome using each clinical risk score and each clinical risk score adjusted for.
Baseline Characteristics of Elderly Participants in the Cardiovascular Health Study,According to Quintiles of Cystatin C Michael G.Shlipak et al N Engl.
Mean (95% CI) fasting s-glucose at baseline and 6-month, 12-month, and 24-month follow-up, overall and by sex (A), and by baseline age (B), education (C),
Mean fasting C-peptide levels (for all subjects [A]) and mean peak C-peptide levels (all subjects [B], adolescents [C], and adults [D])after mixed-meal.
Baseline predictors for risk of cardiovascular events or all-cause mortality among immigrants with language barriers (N = 87,707). *Adjustment for all.
Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics:
Meta-analysis of trials examining the effects of aspirin on risk of CVD events in patients with diabetes. Meta-analysis of trials examining the effects.
Prevalence of nephropathy, retinopathy, and neuropathy in subjects achieving all (A) three targets, (B) two targets, (C) one target, and (D) none, and.
Presentation transcript:

The Cross-sectional and Longitudinal Associations of Diabetic Retinopathy With Cognitive Function and Brain MRI Findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Featured Article: Christina E. Hugenschmidt, James F. Lovato, Walter T. Ambrosius, R. Nick Bryan, Hertzel C. Gerstein, Karen R. Horowitz, Lenore J. Launer, Ronald M. Lazar, Anne M. Murray, Emily Y. Chew, Ronald P. Danis, Jeff D. Williamson, Michael E. Miller, and Jingzhong Ding Diabetes Care Volume 37: December, 2014

STUDY OBJECTIVE Data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial was used to determine whether diabetic retinopathy at baseline predicted changes in brain structure or cognition 40 months later Hugenschmidt C. E. et al. Diabetes Care 2014;37:

STUDY DESIGN AND METHODS Participants from the ACCORD-MIND and ACCORD-Eye substudies were included in analyses of cognition and MRI- derived brain variables Retinopathy was categorized as none, mild nonproliferative, or moderate/severe Tests of cognition included: Mini-Mental State Examination (MMSE) Digit Symbol Substitution Test (DSST) Rey Auditory Verbal Learning Test Stroop test Primary brain outcomes were gray matter and abnormal white matter volumes Hugenschmidt C. E. et al. Diabetes Care 2014;37:

RESULTS Baseline retinopathy was associated with lower gray matter volume Baseline retinopathy predicted a greater change in MMSE and DSST scores at 40 months in each retinopathy category Hugenschmidt C. E. et al. Diabetes Care 2014;37:

CONCLUSIONS Diabetic retinopathy is associated with future cognitive decline in people with type 2 diabetes Patients with type 2 diabetes and retinopathy represent a subgroup at higher risk for future cognitive decline Hugenschmidt C. E. et al. Diabetes Care 2014;37: